Rozycki Todd W, Rogers Roy S, Pittelkow Mark R, McEvoy Marian T, el-Azhary Rokea A, Bruce Alison J, Fiore Joseph P, Davis Mark D P
Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
J Am Acad Dermatol. 2002 Jan;46(1):27-34. doi: 10.1067/mjd.2002.119648.
Oral lichen planus (OLP) is a relatively common, chronic inflammatory condition, which frequently presents with symptoms of pain and irritation. OLP is often difficult to manage. Therefore there is a need for more effective and safer therapies for symptomatic OLP.
Our purpose was to determine the effectiveness of topical tacrolimus as therapy for symptomatic OLP.
A retrospective review was performed of 13 patients with symptomatic OLP treated with topical tacrolimus between September 1999 and September 2000.
Eleven of the 13 patients reported definite symptomatic response to treatment and 2 had no response. Eight patients had a partial response, whereas 3 patients had a complete response with respect to lesion clearance. Seven of the responding patients had no flares with continued treatment. The other 4 patients noted flares soon after stopping the treatment. Side effects were rare and minor.
In this retrospective case series of 13 patients, topical tacrolimus was well tolerated and appeared to be an effective therapy to control symptoms and clear lesions of OLP.
口腔扁平苔藓(OLP)是一种相对常见的慢性炎症性疾病,常伴有疼痛和刺激症状。OLP通常难以治疗。因此,需要更有效、更安全的疗法来治疗有症状的OLP。
我们的目的是确定外用他克莫司治疗有症状OLP的有效性。
对1999年9月至2000年9月期间接受外用他克莫司治疗的13例有症状OLP患者进行回顾性研究。
13例患者中有11例报告对治疗有明确的症状改善反应,2例无反应。8例患者有部分反应,3例患者病变完全清除。7例有反应的患者在持续治疗期间无病情复发。另外4例患者在停药后不久病情复发。副作用罕见且轻微。
在这个13例患者的回顾性病例系列中,外用他克莫司耐受性良好,似乎是控制OLP症状和清除病变的有效疗法。